Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

por Vetter, C S, Lieb, W, Bröcker, E-B, Becker, J C
Publicado 2004

Anorectal melanoma: surgical management guidelines according to tumour thickness

por Weyandt, G H, Eggert, A O, Houf, M, Raulf, F, Bröcker, E B, Becker, J C
Publicado 2003

Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma

por Wobser, M, Voigt, H, Eggert, A O, Houben, R, Kauczok, C S, Bröcker, E B, Becker, J C
Publicado 2007

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

por Becker, J C, Terheyden, P, Kämpgen, E, Wagner, S, Neumann, C, Schadendorf, D, Steinmann, A, Wittenberg, G, Lieb, W, Bröcker, E-B
Publicado 2002

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells

por Leikam, C, Hufnagel, A L, Otto, C, Murphy, D J, Mühling, B, Kneitz, S, Nanda, I, Schmid, M, Wagner, T U, Haferkamp, S, Bröcker, E-B, Schartl, M, Meierjohann, S
Publicado 2015

Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (A...

por Atzpodien, J, Neuber, K, Kamanabrou, D, Fluck, M, Bröcker, E B, Neumann, C, Rünger, T M, Schuler, G, von den Driesch, P, Müller, I, Paul, E, Patzelt, T, Reitz, M
Publicado 2002